Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
1
self-reported band not used
Founded
Not recorded
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Partnership
self-reported
Legal entity
1 brand → 1 confirmed entity
JAGUAHR THERAPEUTICS PTE. LTD.Entity record →
UEN201926902D
Legal entities
Show as table · JAGUAHR Therapeutics: 1 registry entity
| JAGUAHR THERAPEUTICS PTE. LTD. | UEN 201926902D |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
JAGUAHR Therapeutics is developing novel immuno-oncology therapeutics targeting the Aryl Hydrocarbon Receptor (AhR) pathway
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG3 Temasek Avenue; Level 18; SingaporePrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
Which legal entity operates under JAGUAHR Therapeutics?
One Singapore entity on ACRA: JAGUAHR THERAPEUTICS PTE. LTD. (UEN 201926902D), high confidence.
How many people work at JAGUAHR Therapeutics?
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does JAGUAHR Therapeutics have offices?
One address on record, Singapore only. Primary: 3 Temasek Avenue, Level 18, Singapore.
Has JAGUAHR Therapeutics raised funding?
None linked to this brand.
Which companies are listed alongside JAGUAHR Therapeutics?
Three peer profiles on record: ChemLex and DotBio.